Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM171B antisense RNA 1 (FAM171B-AS1) is a putative long non-coding antisense RNA transcript located at the FAM171B gene locus (NCBI Gene ID: 165215). While FAM171B protein has been implicated in processes like cancer progression and immune cell recruitment, there is currently no direct evidence in the literature for the distinct existence, function, or therapeutic targeting of "FAM171B-AS1" as a canonical, characterized antisense RNA molecule. The entry as "FAM171B and ITGAV antisense RNA 1" may be incorrect or a result of gene annotation artifacts. In contrast, FAM171B protein is overexpressed in several cancers and may regulate tumor progression[1][3], but published data on an antisense RNA at this locus are lacking. Antisense RNAs as a class are emerging as key regulatory molecules and possible RNA-based therapy targets, but no specific drugs or validated disease associations exist for FAM171B-AS1 at present[2]. Clarifications and Notable Issues: - "FAM171B-AS1" is not well-characterized as a distinct, canonical antisense RNA in curated genetic databases or the scientific literature, although the FAM171B gene itself (and its protein product) is supported[3]. - The compound name "FAM171B and ITGAV antisense RNA 1" does not correspond to any recognized entry in major gene or lncRNA databases, and may represent a misannotation. - No evidence exists to support the classification of this molecule as a classic therapeutic target (such as a receptor, enzyme, or transporter). - No reports were found of small-molecule or RNA-based drugs targeting FAM171B-AS1. If you are seeking structured data for a true lncRNA antisense of FAM171B, additional bioinformatic validation would be needed. There is a possibility this name reflects a misannotation, and as such is_incorrect: true is returned. Summary of key points: - FAM171B protein is recognized; FAM171B-AS1 lncRNA is poorly characterized or may not exist as a standardized entity. - The name as presented likely does not reflect an established or druggable target. - Disease relevance pertains only to the FAM171B protein, not the antisense RNA. - No directly interacting drugs, mechanisms, or biomarkers have been characterized for "FAM171B-AS1".
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 171, member B antisense RNA 1 (FAM171B-AS1).